Tak Paul Peter (CIK 0001873905)

Latest company ownership

CADL - Candel Therapeutics, Inc.

Role: CEO

Shares held

268,566

Last filed at

Jun 26, 2025

Confidence Score

49.5

2025Q4

Confidence Score History

2021Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Mar 18, 2025	Mar 20, 2025	Candel Therapeutics, Inc.	CEO	Sell	25.0	-26,172	-10.39%	✓	$229.6K
Jan 15, 2025	Jan 17, 2025	Candel Therapeutics, Inc.	CEO	Sell	42.5	-21,704	-7.93%	✗	$156.8K
Jan 8, 2025	Jan 10, 2025	Candel Therapeutics, Inc.	CEO	Sell	42.5	-21,172	-7.18%	✗	$174K
Nov 29, 2024	Dec 3, 2024	Candel Therapeutics, Inc.	CEO	Sell	42.5	-48,847	-14.21%	✗	$222.5K
Jul 17, 2024	Jul 19, 2024	Candel Therapeutics, Inc.	CEO	Sell	42.5	-22,528	-6.38%	✗	$145.8K
Jul 11, 2024	Jul 15, 2024	Candel Therapeutics, Inc.	CEO	Sell	42.5	-20,293	-5.43%	✗	$121.2K
Nov 28, 2023	Nov 30, 2023	Candel Therapeutics, Inc.	CEO	Sell	46.3	-43,443	-10.42%	✗	$39.1K
Dec 8, 2022	Dec 12, 2022	Candel Therapeutics, Inc.	CEO	Buy	91.3	+15,985	63.94%	✗	$30K
Jul 29, 2021	Aug 2, 2021	Candel Therapeutics, Inc.	CEO	Buy	95.0	+25,000	100.00%	✗	$200K